ProfileGDS5678 / 1459946_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 38% 39% 39% 39% 37% 38% 39% 38% 39% 39% 39% 39% 39% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.913538
GSM967853U87-EV human glioblastoma xenograft - Control 22.8922439
GSM967854U87-EV human glioblastoma xenograft - Control 32.8958739
GSM967855U87-EV human glioblastoma xenograft - Control 42.8401639
GSM967856U87-EV human glioblastoma xenograft - Control 52.8074737
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.9496238
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9612539
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.8684538
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.8745839
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.8787439
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.8776439
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.8649139
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.887239
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.8856839